Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.56 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.56 |
| ▸ | RARB | P10826 | 7/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 7/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | RARA | P10276 | 1/20 | 0.55 |
| ▸ | MTOR | P42345 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.51 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21656855 | 0.99 | RARB (0.57) | GRM2CYSLTR1RARBOPRM1OPRD1 | |
| SCHEMBL21656822 | 0.96 | GRM2 (0.57) | GRM2CYSLTR1RARBOPRM1OPRD1 | |
| SCHEMBL21628768 | 0.91 | GRM2 (0.62) | GRM2CYSLTR1OPRM1OPRD1OPRK1 | |
| SCHEMBL21628719 | 0.89 | OPRM1 (0.65) | OPRM1OPRD1OPRK1GRIN2DGRIN3B | |
| SCHEMBL21628559 | 0.88 | OPRM1 (0.64) | OPRM1OPRD1OPRK1GRIN2DGRIN3B | |
| SCHEMBL21656861 | 0.88 | MAPT (0.56) | OPRM1OPRD1OPRK1MAPTSMN1; SMN2 | |
| SCHEMBL21628571 | 0.86 | OPRM1 (0.65) | OPRM1OPRD1OPRK1SMN1; SMN2PLA2G4A | |
| SCHEMBL21656682 | 0.86 | MAPT (0.55) | OPRM1OPRD1OPRK1MAPTSMN1; SMN2 | |
| SCHEMBL21628729 | 0.86 | OPRM1 (0.49) | GRM2CYSLTR1OPRM1OPRD1OPRK1 | |
| SCHEMBL21656689 | 0.86 | PDE4B (0.52) | GRM2CYSLTR1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | GRM2 4777/4885CYSLTR1 2413/4885RARB 1144/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | GRM2 4787/4885CYSLTR1 2381/4885RARB 1064/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | GRM2 4777/4885CYSLTR1 2413/4885RARB 1144/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | GRM2 4083/4885CYSLTR1 1537/4885RARB 1531/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | GRM2 4777/4885CYSLTR1 2413/4885RARB 1144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.